Adoptive transfer of fibrocytes enhances splenic T-cell numbers and survival in septic peritonitis

Shock

Volumn 40, Issue 2, 2013, Pages 106-114

  Nemzek, Jean A ^a   Fry, Christopher ^a   Moore, Bethany B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cell therapy; Immunomodulation; Sepsis; TH1 TH2 cytokines

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PERITONEAL DIALYSIS FLUID; SODIUM CHLORIDE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL LOAD; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CECUM; CELL COUNT; CELL CULTURE; CELL SURVIVAL; CELL TYPE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; EXPERIMENTAL LIGATION; FEMALE; FIBROBLAST; FIBROCYTE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; ORGAN INJURY; OUTCOME ASSESSMENT; PERITONITIS; PROTEIN EXPRESSION; SEPSIS; SPLEEN LYMPHOCYTE; SURVIVAL; T LYMPHOCYTE; TH1 CELL; UREA NITROGEN BLOOD LEVEL;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; PERITONITIS; SEPSIS; T-LYMPHOCYTES;

EID: 84880837053     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31829c3c68     Document Type: Article

References (34)

1. Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A: Inpatient care for septicemia or sepsis: A challenge for patients and hospitals. NCHS data brief no 62. Hyattsville, MD: National Center for Health Statistics, 2011.
2. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24(7): 1125-1128, 1996.
3. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E, et al.: Caspase inhibitors improve survival in sepsis: A critical role of the lymphocyte. Nat Immunol 1(6): 496-501, 2000.
4. Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF, Zollner KM, Buchman TG, Korsmeyer SJ, Karl IE: Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 162(7):4148-4156, 1999.
5. Efron P,Moldawer LL: Sepsis and the dendritic cell. Shock 20(5):386-401, 2003.
6. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, Korsmeyer SJ, Karl IE: Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci 96(25):14541-14546, 1999.
7. Unsinger J, McGlynn M, Kasten KR, Hoekzema AS, Watanabe E, Muenzer JT, McDonough JS, Tschoep J, Ferguson TA, McDunn JE, et al.: IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 184(7):3768-3779, 2010.
8. Inoue S, Bo L, Bian J, Unsinger J, Chang K, Hotchkiss RS: Dose-dependent effect of anti-CTLA-4 on survival in sepsis. Shock 36(1):38-44, 2011.
9. Scumpia PO, Delano MJ, Kelly-Scumpia KM, Weinstein JS, Wynn JL, Winfield RD, Xia C, Chung CS, Ayala A, Atkinson MA, et al.: Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood 110(10):3673-3681, 2007.
10. Benjamim CF, Lundy SK, Lukacs NW, Hogaboam CM, Kunkel SL: Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood 105(9): 3588-3595, 2005.
11. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A: Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1(1):71-81, 1994.
12. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R: Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160(1):419-425, 1998.
13. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C, Wilke CA, Toews GB: CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166(3):675-684, 2005.
14. Strieter RM, Gomperts BN, Keane MP: The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 117(3):549-556, 2007.
15. Curnow SJ, Fairclough M, Schmutz C, Kissane S, Denniston AK, Nash K, Buckley CD, Lord JM, Salmon M: Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum. PLoS ONE [Electronic Resource] 5(3):e9730, 2010.
16. Kisseleva T, von Kockritz-Blickwede M, Reichart D, McGillvray SM, Wingender G, Kronenberg M, Glass CK, Nizet V, Brenner DA: Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection. J Mol Med 89(10):997-1013, 2011.
17. Chesney J, Bacher M, Bender A, Bucala R: The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 94(12):6307-6312, 1997.
18. Metz CN: Fibrocytes: A unique cell population implicated in wound healing. Cell Mol Life Sci 60(7):1342-1350, 2003.
19. Balmelli C, Alves MP, Steiner E, Zingg D, Peduto N, Ruggli N, Gerber H, McCullough K, Summerfield A: Responsiveness of fibrocytes to toll-like receptor danger signals. Immunobiology 212(9-10):693-699, 2007.
20. Balmelli C, Ruggli N, McCullough K, Summerfield A: Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. J Leukoc Biol 77(6):923-933, 2005.
21. Medina A, Ghahary A: Fibrocytes can be reprogrammed to promote tissue remodeling capacity of dermal fibroblasts. Mol Cell Biochem 344(1-2):11-21, 2010.
22. Medina A, Ghahary A: Reprogrammed fibrocytes induce a mixed TH1/TH2 cytokine response of naive CD4(+) T cells. Mol Cell Biochem 346(1-2): 89-94, 2011.
23. De Clerck LS, Bridts CH, Mertens AM, Moens MM, Stevens WJ: Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. J Immunol Methods 172(1):115-124, 1994.
24. Hugunin KM, Fry C, Shuster K, Nemzek JA: Effects of tramadol and buprenorphine on select immunologic factors in a cecal ligation and puncture model. Shock 34(3):250-260, 2010.
25. Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A: CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 440(2):128-133, 2002.
26. Younes SA, Punkosdy G, Caucheteux S, Chen T, Grossman Z, Paul WE: Memory phenotype CD4 T cells undergoing rapid, nonburst-like, cytokinedriven proliferation can be distinguished from antigen-experienced memory cells. PLoS Biol 9(10):e1001171, 2011.
27. Wong P, Pamer EG: Cutting edge: Antigen-independent CD8 T cell proliferation. J Immunol 166(10):5864-5868, 2001.
28. Lu J, Giuntoli RL 2nd, Omiya R, Kobayashi H, Kennedy R, Celis E: Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes. Clin Cancer Res 8(12):3877-3884, 2002.
29. Swain SL, Hu H, Huston G: Class IIYindependent generation of CD4 memory T cells from effectors. Science 286(5443):1381-1383, 1999.
30. Peng H, Herzog EL: Fibrocytes: Emerging effector cells in chronic inflammation. Curr Opin Pharmacol 12(4):491-496, 2012.
31. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, et al.: Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)Ydependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15(1): 42-49, 2009.
32. Caux C, Massacrier C, Vanbervliet B, Barthelemy C, Liu YJ, Banchereau J: Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 6(8):1177-1185, 1994.
33. Muenzer JT, Davis CG, Chang K, Schmidt RE, Dunne WM, Coopersmith CM, Hotchkiss RS: Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun 78(4):1582-1592, 2010.
34. Galligan CL, Fish EN: Circulating fibrocytes contribute to the pathogenesis of arthritis. Arthritis Rheum 64(11):3583-3593, 2012.